Veytics Intelligence
2026-10-17 · NASDAQ

Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share

Key PointsRegeneron’s revenue is growing at a good clip despite declining Eylea sales.

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.